ESTRELLA IMMUNOPHARMA, INC. Total Liabilities
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Total Liabilities of $9.26 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-13
- 2026-06-30: Liabilities $9.26M.
- 2026-03-31: Liabilities $8.93M.
- 2025-12-31: Liabilities $13.54M.
- 2025-09-30: Liabilities $13.36M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $9.26M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $8.93M 10-Q · filed 2026-05-18 | |
| 2025-12-31 | $13.54M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $13.36M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $9.08M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $4.28M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.00M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $2.99M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $180.70K 10-KT · filed 2025-03-25 | |
| 2024-03-31 | $138.49K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $398.73K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $17.28M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $9.77M 10-K · filed 2024-09-27 | $2.99M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $2.77M 10-Q · filed 2023-05-18 | |
| 2022-12-31 | $2.65M 10-Q · filed 2023-08-01 | |
| 2022-09-30 | $2.29M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.71M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.58M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.62M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $1.65M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |